Roche And Shandong Gallo Virology Institute To Establish Gene Diagnostics Center
This article was originally published in PharmAsia News
Executive Summary
Roche Diagnostics APAC and Shandong Academy of Medical Sciences' Gallo Virology Institute recently established China's first personalized gene diagnostics center. The facility will provide personalized medicine and technologies to fight HIV/AIDS and other viral infectious diseases to meet medium- and long-term demands of the changing healthcare market in China. Both parties also signed a letter of intent to jointly conduct research in the field of diagnostics. Personalized medical care is a core strategy for Roche globally. With such solutions, physicians can conduct molecular testing and offer patients the most efficient and appropriate treatment programs. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.